Developing advanced therapies and treatments utilizing the latest research and technologies to improve outcomes for children and their families.
Pipelining Therapies
A Faster Approach using existing research, artificial intelligence, licensing agreements, and process automation we hope to deliver rapid orphan drug therapies.
A Holistic Solution
At Arcadia Therapeutics, we thrive to integrate testing, supplementation, therapies, and technology to produce the best possible results for families.*
Research Focused
Our principal aim is to help children who are suffering from pathology caused by deficiencies or undiagnosed infections. We intend on building a suite of testing panels that will help us to quickly determine a child’s principal issue and help to develop strategies to resolve them.*
Personalization of therapies has been a goal of medicine for a long time, we hope that we can deliver this through advanced testing and technology. It is our goal to ensure any therapies that are produced are also commercially viable so that we can continue to grow our ecosystem of therapies for those in need.*
Present Areas of Investigation
PANDAS Syndrome: Dr. Chris Spiekerman, one of the world’s leading expert on PANDAS syndrome and our organizations Medical Director is focusing his efforts on the development of several novel therapies for treating PANDAS. It is our intent to initiate several phase 1 clinical trials with the FDA to investigate the safety and efficacy of these therapies.*
Advanced Colic Testing: We have found in our research that Colic in some cases may be due to pathological overgrowth of bacteria in the gut causing adverse outcomes for infants. We are in the process of developing a Colic testing panel for infants to help identify these overgrowths early and effectively.*
Autism Supplementation: Through the utilization of blood testing the research has found that some children who suffer from Autism and other neurological disorders can benefits from certain supplementation blends. We are working with partners to exploit this research and deliver this nutrients in an easy to administer format.*
Cerecell AC2 Enhanced Nutritional Supplementation
Based on a double blind study performed by Arizona State University, positive results were seen for children with autism who received specific vitamin supplementation. Cerecell AC2 Enhanced Nutritional Supplementation attempts to provide similar nutritional supplementation in a highly palatable solution that can be given to children who have difficulties consuming supplements.*
Comprehensive Testing Panels
Testing panels specifically for children with Pandas Syndrome that will reduce the overall number of blood draws needed to identify the best course of treatment. We are also working on similar testing Panels for children with Autism for vitamin supplementation.*
Contact Us
Join us on this transformative journey as we unlock the immense potential of regenerative treatments for a brighter and healthier future.
©2023 Arcadia Therapeutics Corp (ATC) – All Rights Reserved.
*The products and/or statements made about specific products or treatments found on this website have not been evaluated by the United States Food and Drug Administration and are not intended to diagnose, cure or prevent disease.
Dr. Spiekerman recommends that FDA-approved treatments for autism, including Occupational Therapy, Feeding Therapy, Speech Therapy, ABA, Music Therapy, and any other FDA-approved modalities implemented by the patient’s provider, should be used as the first line of treatment and must be ongoing for a consult.
For CPAE, PANDAS, and PANS, Dr. Spiekerman endorses all standard FDA therapies as directed by the University of Arizona CPAE clinic, under the Steele Center, considering them the Gold Standard for treating children with these conditions.
The tests provided at Arcadia Pediatric Consulting are intended as adjunct tools to assist with diagnostic criteria only. They are not used to create a diagnosis but rather to aid in the diagnostic process. These tests are not a substitute for a thorough investigation of a child’s symptoms.
Dr. Spiekerman makes no guarantees regarding the improvement of any diagnoses. He acknowledges that when dealing with complex issues and diagnoses, a patient’s symptoms can worsen and may even become permanent.
Dr. Spiekerman is an owner of Cerecell and stands to gain financially from its sale. This supplement, which he may recommend, is available on the website Cerecell.com. He agrees with the FDA that Cerecell is not intended to diagnose, treat, or cure any disease. He always recommends using standard FDA-approved modalities as the first line of treatment, which should be continued under the direction of the patient’s primary care provider.
Dr. Spiekerman insists that any protocols created must have the agreement of both the primary care provider and the family. If either the primary care provider or the family is uncomfortable with the recommendations, the protocol should not be implemented.